skip to Main Content

Simple solutions to complex medical needs for the benefit of the patients Simple solutions to complex medical needs for the benefit of the patients

Medimaps Group is a leading global medical software analytics company founded by a group of clinical practitioners and researchers, based in Switzerland with offices in the US and in France. It specialises in the engineering, research, development, and commercialisation of medical software applications based on patented multi-purpose technologies.

Its flagship product, the TBS iNsight™ (Osteo) software application has been used for years in clinical practice to better predict fracture risk in the field of osteoporosis. It has become the gold standard for bone structure assessment in routine clinical practice.

This core technology has been further developed and new medical applications have been created in the dental and orthopaedics fields. Medimaps Group is also exploring applications in veterinary medicine and oncology.

Our team of experts provides better medical outcomes
by giving doctors innovative digital health solutions
to identify patients at clinical risk, fine-tune therapy decisions
and improve disease management.
We help doctors provide
better patient care and quality of life
through improved tissue structure assessments.


Prof. Didier Hans, PhD, MBA


Didier Hans co-founded Med-Imaps SA in 2006 and became CEO of Medimaps Group in 2012.…

Read more »

Dr. Lionel Beaugé, Ph.D.

Chief Product and Technology Officer

Lionel Beaugé joined Medimaps group in 2020 bringing a strong background in IT, Technologies, Healthcare, Software Development,…

Read more »

Sophie Bein Mack, MBA

Chief Operating Officer

Sophie Bein Mack joined Medimaps Group in January 2020, to review, optimize and develop the organization…

Read more »

Dr. Astrid Bardelaye, PhD

Chief Administrative Officer

Astrid Bardelaye manages Medimaps Group's administration, HR and finance department and…

Read more »

Dr. Shelley Horn, MBA

Business Development Officer

Based in the US, Shelley Horn leads Medimaps Group's global investor acquisition and development activity…

Read more »


Didier Hans

Chairman of the Board (and CEO) Didier Hans co-founded Med-Imaps SA in 2006 and became CEO of Medimaps Group in 2012. He currently drives the…

Read more »

Pierre Strübin

Pierre focuses on legal and financial aspects and is part of the compensation Committee. He serves as Chairman for the Fondation Genevoise pour l'Innovation Technologique…

Read more »

Xavier Castelli

Xavier has worked for several worldwide companies in the pharmaceutical field and machine tool industry; CRI-DAN SA., Toyoda Machine Works Ltd. He created Delpharm laboratory,…

Read more »


Prof. J. A. Kanis

Professor Emeritus in Human Metabolism at the University of Sheffield and President Emeritus of the…

Read more »

Prof. H. K. Genant

Professor Emeritus at the UCSF-University of California San Francisco, US; Expert in radiology, medicine, orthopaedic…

Read more »

Dr. T. Fuerst

Chief Science Officer at BioClinica Inc., USA; Expert in imaging in clinical trials, bone densitometry,…

Read more »

Prof. Dr. C. C. Glüer

Professor of Medical Physics at Christian Albrechts University, Kiel, Germany; Expert in the development of…

Read more »

Prof. P. Hadji

Head of the Department of Endocrinology, Reproductive Medicine and Osteoporosis and Professor of Obstetrics, Gynaecology…

Read more »


Parties interested in learning more about Medimaps Group investment opportunities should contact Dr. Shelley Horn, Business Development Officer, at +1 800 321 4472 or via email:

Back To Top